ANNALY MORTGAGE MANAGEMENT, INC.





                                4,000,000 SHARES
              6.00% SERIES B CUMULATIVE CONVERTIBLE PREFERRED STOCK





                             UNDERWRITING AGREEMENT







                                  APRIL 6, 2006











                             UNDERWRITING AGREEMENT



                                                                   April 6, 2006

MERRILL LYNCH & CO.
Merrill Lynch, Pierce, Fenner & Smith Incorporated
Bear, Stearns & Co. Inc.
c/o Merrill Lynch & Co.
Merrill Lynch, Pierce, Fenner & Smith Incorporated
4 World Financial Center
New York, New York 10080

Ladies and Gentlemen:

                  Annaly Mortgage Management, Inc., a Maryland corporation (the
"Company"), proposes to issue and sell to the underwriters named in Schedule A
annexed hereto (the "Underwriters"), for whom Merrill Lynch & Co., Merrill
Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch") and Bear, Stearns &
Co. Inc. are acting as representatives, an aggregate of 4,000,000 shares (the
"Firm Shares") of series B cumulative convertible preferred stock (the "Series B
Preferred Stock"), of the Company. In addition, solely for the purpose of
covering over-allotments, the Company proposes to grant to the Underwriters the
option to purchase from the Company up to an additional 600,000 shares of Series
B Preferred Stock (the "Additional Shares"). The Firm Shares and the Additional
Shares are hereinafter collectively sometimes referred to as the "Shares." The
Shares are described in the Prospectus which is referred to below. The Shares
will be established by the Articles Supplementary of 6.00% Series B Cumulative
Convertible Preferred Stock (the "Articles Supplementary"), in the form of
Exhibit A attached hereto.

                  The Company has filed, in accordance with the provisions of
the Securities Act of 1933, as amended, and the rules and regulations thereunder
(collectively, the "Securities Act"), with the Securities and Exchange
Commission (the "Commission") a registration statement on Form S-3 (File No.
333-120920), as amended, including a base prospectus, with respect to the
Shares, and which incorporates by reference documents which the Company has
filed or will file in accordance with the provisions of the Securities Exchange
Act of 1934, as amended, and the rules and regulations thereunder (collectively,
the "Exchange Act"). The Company has prepared a prospectus supplement (the
"Prospectus Supplement") to the base prospectus included as part of such
registration statement setting forth the terms of the offering, sale and plan of
distribution of the Shares and additional information concerning the Company and
its business. The Company has furnished to Merrill Lynch, for use by the
Underwriters and by dealers, copies of one or more preliminary prospectuses,
containing the base prospectus included as part of such registration statement,
as supplemented by a preliminary Prospectus Supplement, and including the
documents incorporated in such base prospectus by reference (each, a
"Preliminary Prospectus"), relating to the Shares. Except where the context
otherwise requires, such





registration statement, as amended when it became effective, including all
documents filed as part thereof or incorporated by reference therein, and
including any information contained in a Prospectus (as defined below)
subsequently filed with the Commission pursuant to Rule 424(b) under the
Securities Act and also including any other registration statement filed
pursuant to Rule 462(b) under the Securities Act, collectively, are herein
called the "Registration Statement," and the base prospectus, including all
documents incorporated therein by reference, included in the Registration
Statement, as supplemented by the Prospectus Supplement, in the form filed by
the Company with the Commission pursuant to Rule 424(b) and Rule 430(A) under
the Securities Act on or before the second Business Day (as defined below)
following the date of this Underwriting Agreement (the "Agreement") (or on such
other day as the parties may mutually agree), is herein called the "Prospectus."
The information included in such prospectus that was omitted from such
registration statement at the time it became effective but that is deemed to be
part of such registration statement at the time it became effective pursuant to
paragraph (b) of Rule 430A is referred to as "Rule 430A Information." Any
reference herein to the Registration Statement, the Prospectus, any Preliminary
Prospectus or any amendment or supplement thereto shall be deemed to refer to
and include the documents incorporated by reference therein, and any reference
herein to the terms "amend," "amendment" or "supplement" with respect to the
Registration Statement, the Prospectus or any Preliminary Prospectus shall be
deemed to refer to and include the filing after the execution hereof of any
document with the Commission deemed to be incorporated by reference therein. For
purposes of this Agreement, all references to the Registration Statement, the
Prospectus, any Preliminary Prospectus or to any amendment or supplement thereto
shall be deemed to include any copy filed with the Commission pursuant to its
Electronic Data Gathering Analysis and Retrieval System ("EDGAR"), and such copy
shall be identical in content to any Prospectus or Preliminary Prospectus
delivered to the Underwriters for use in connection with the offering of the
Shares.

                  All references in this Agreement to financial statements and
schedules and other information which is "contained," "included" or "stated" in
the Registration Statement, any Preliminary Prospectus or the Prospectus (or
other references of like import) shall be deemed to mean and include all such
financial statements and schedules and other information which is incorporated
by reference in the Registration Statement, any Preliminary Prospectus or the
Prospectus, as the case may be; and all references in this Agreement to
amendments or supplements to the Registration Statement, any preliminary
prospectus or the Prospectus shall be deemed to mean and include the filing of
any document under the Securities Exchange Act of 1934 (the "1934 Act") which is
incorporated by reference in the Registration Statement, such Preliminary
Prospectus or the Prospectus, as the case may be.

                  The Company and the Underwriters agree as follows:

                  1. SALE AND PURCHASE. Upon the basis of the warranties and
representations and subject to the terms and conditions herein set forth, the
Company agrees to issue and sell the Firm Shares to the several Underwriters,
and each of the Underwriters, severally and not jointly, agrees to purchase from
the Company the respective number of Firm Shares (subject to such adjustment as
Merrill Lynch may determine to avoid fractional shares) set forth opposite the
name of such Underwriter in Schedule A annexed hereto at a purchase price of
$24.25 per Share. The Company is advised by Merrill Lynch that the Underwriters
intend (i) to make a public offering of the Shares as soon as the Underwriters
deem advisable after this Agreement has been


                                      -2-



executed and delivered and (ii) initially to offer the Firm Shares upon the
terms set forth in the Prospectus. The Underwriters may from time to time
increase or decrease the public offering price after the initial public offering
to such extent as they may determine.

                  In addition, the Company hereby grants to the several
Underwriters the option to purchase, and upon the basis of the warranties and
representations and subject to the terms and conditions herein set forth, the
Underwriters shall have the right to purchase, severally and not jointly, from
the Company ratably in accordance with the number of Firm Shares to be purchased
by each of them (subject to such adjustment as Merrill Lynch shall determine to
avoid fractional shares), all or a portion of the Additional Shares as may be
necessary to cover over-allotments made in connection with the offering of the
Firm Shares, at the same purchase price per share to be paid by the Underwriters
to the Company for the Firm Shares. This option may be exercised by Merrill
Lynch on behalf of the several Underwriters at any time and from time to time on
or before the thirtieth day following the date hereof, by written notice to the
Company. Each such notice shall set forth the aggregate number of Additional
Shares as to which the option is being exercised and the date and time when
Additional Shares are to be delivered (such date and time being herein referred
to as an "additional time of purchase"); provided, however, that an additional
time of purchase shall not be (i) earlier than the time of purchase (as defined
below) or (ii) later than the tenth Business Day after the date on which the
option shall have been exercised. The number of Additional Shares to be sold to
each Underwriter shall be the number which bears the same proportion to the
aggregate number of Additional Shares being purchased as the number of Firm
Shares set forth opposite the name of such Underwriter on Schedule A hereto
bears to the aggregate number of Firm Shares (subject, in each case, to such
adjustment as Merrill Lynch may determine to eliminate fractional shares). As
used herein "Business Day" shall mean a day on which the New York Stock Exchange
(the "NYSE") is open for trading and commercial banks in the City of New York
are open for business.

                  2. PAYMENT AND DELIVERY. Payment of the purchase price for the
Firm Shares shall be made to the Company by federal funds wire transfer against
delivery of the certificates for the Firm Shares to Merrill Lynch through the
facilities of the Depository Trust Company ("DTC") for the respective accounts
of the Underwriters. Such payment and delivery shall be made at 10:00 A.M., New
York City time, on April 12, 2006 (unless another time shall be agreed to by
Merrill Lynch and the Company or unless postponed in accordance with the
provisions of Section 8 hereof). The time at which such payment and delivery are
actually made is herein sometimes called the "time of purchase." Certificates
for the Firm Shares shall be delivered to Merrill Lynch, through the facilities
of DTC, in definitive form in such names and in such denominations as Merrill
Lynch shall specify no later than the second Business Day preceding the time of
purchase. For the purpose of expediting the checking of the certificates for the
Firm Shares by Merrill Lynch, the Company agrees to make such certificates
available to Merrill Lynch for such purpose at least one full Business Day
preceding the time of purchase.

                  Payment of the purchase price for Additional Shares shall be
made at each additional time of purchase in the same manner and at the same
office as the payment for the Firm Shares. Certificates for Additional Shares
shall be delivered to Merrill Lynch, through the facilities of DTC, in
definitive form in such names and in such denominations as Merrill Lynch shall
specify no later than the second Business Day preceding each additional time of
purchase. For the purpose of expediting the checking of the certificates for
Additional Shares by Merrill


                                      -3-




Lynch, the Company agrees to make such certificates available to Merrill Lynch
for such purpose at least one full Business Day preceding each additional time
of purchase.

                  3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY. The Company
represents and warrants to each of the Underwriters as of the date hereof, the
Applicable Time referred to in Section 3(b), as of the time of purchase and, if
applicable, at each additional time of purchase that:

                  (a) The Company meets the requirements for use of Form S-3
under the Securities Act. The Registration Statement has been filed with the
Commission and has been declared effective under the Securities Act. The Company
has not received, and has no notice of, any order of the Commission preventing
or suspending the use of the Registration Statement, or threatening or
instituting proceedings for that purpose. Any statutes, regulations, contracts
or other documents that are required to be described in the Registration
Statement or the Prospectus or to be filed as exhibits to the Registration
Statement have been so described or filed. The Prospectus Supplement has been or
will be so prepared and will be filed pursuant to Rule 424(b) of the Securities
Act on or before the second Business Day following the date of this Agreement or
on such other day as the parties may mutually agree. The Preliminary Prospectus,
at the time of filing thereof, conformed in all material respects to the
requirements of the Securities Act. Copies of the Registration Statement, the
Preliminary Prospectus and the Prospectus, any such amendments or supplements
and all documents incorporated by reference therein that were filed with the
Commission on or prior to the date of this Agreement (including one fully
executed copy of each of the Registration Statement and of each amendment
thereto for the Underwriters) have been delivered to the Underwriters and their
counsel. The Company has not distributed any offering material in connection
with the offering or sale of the Shares other than the Registration Statement,
the Preliminary Prospectus, the Prospectus, Issuer General Use Free Writing
Prospectuses (as defined below) or any other materials, if any, permitted by the
Securities Act.

                  (b) Each part of the Registration Statement, when such part
became or becomes effective or was or is filed with the Commission, and the
Prospectus and any amendment or supplement thereto, on the date of filing
thereof with the Commission and at the time of purchase and, if applicable, at
each additional time of purchase, conformed or will conform in all material
respects with the requirements of the Securities Act. Each part of the
Registration Statement, when such part became or becomes effective or was or is
filed with the Commission, did not or will not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading. The Prospectus and any
amendment or supplement thereto, on the date of filing thereof with the
Commission and at the time of purchase and, if applicable, at each additional
time of purchase, did not or will not include an untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading,
except that the foregoing shall not apply to statements in, or omissions from,
any such document in reliance upon, and in conformity with, written information
concerning the Underwriters that was furnished in writing to the Company by
Merrill Lynch, on behalf of the several Underwriters, specifically for use in
the preparation thereof.


                                      -4-



                  (c) As of the Applicable Time neither (x) the Issuer General
Use Free Writing Prospectus(es) (as defined below) issued at or prior to the
Applicable Time and the Statutory Prospectus (as defined below) as of the
Applicable Time, all considered together (collectively, the "General Disclosure
Package"), nor (y) any individual Issuer Limited Use Free Writing Prospectus,
when considered together with the General Disclosure Package, included any
untrue statement of a material fact or omitted to state any material fact
necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.

                  As of the time of the filing of the Final Term Sheet, the
General Disclosure Package, when considered together with the Final Term Sheet
(as defined in Section 4(b)), will include any untrue statement of a material
fact or omitted to state any material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were
made, not misleading.

                  As used in this subsection and elsewhere in this Agreement:

                  "Applicable Time" means 9:00 pm (Eastern time) on April 6,
2006 or such other time as agreed by the Company and Merrill Lynch.

                  "Issuer Free Writing Prospectus" means any "issuer free
writing prospectus," as defined in Rule 433 of the 1933 Act Regulations ("Rule
433"), relating to the Shares that (i) is required to be filed with the
Commission by the Company, (ii) is a "road show that is a written communication"
within the meaning of Rule 433(d)(8)(i) whether or not required to be filed with
the Commission or (iii) is exempt from filing pursuant to Rule 433(d)(5)(i)
because it contains a description of the Shares or of the offering that does not
reflect the final terms, in each case in the form filed or required to be filed
with the Commission or, if not required to be filed, in the form retained in the
Company's records pursuant to Rule 433(g).

                  "Issuer General Use Free Writing Prospectus" means any Issuer
Free Writing Prospectus that is intended for general distribution to prospective
investors, as evidenced by it being specified in Schedule B hereto.

                  "Issuer Limited Use Free Writing Prospectus" means any Issuer
Free Writing prospectus that is not an Issuer General Use Free Writing
Prospectus.

                  "Statutory Prospectus" as of any time means the prospectus
relating to the Shares that is included in the Registration Statement
immediately prior to that time, including any document incorporated by reference
therein.

                  Each Issuer Free Writing Prospectus, as of its issue date and
at all subsequent times through the completion of the public offer and sale of
the Shares or until any earlier date that the Company notified or notifies
Merrill Lynch as described in the next sentence, did not, does not and will not
include any information that conflicted, conflicts or will conflict with the
information contained in the Registration Statement or the Prospectus, including
any document incorporated by reference therein, and any preliminary or other
prospectus deemed to be a part thereof that has not been superseded or modified.



                                      -5-



                  The representations and warranties in this subsection shall
not apply to statements in or omissions from the Registration Statement, the
Prospectus or any Issuer Free Writing Prospectus made in reliance upon and in
conformity with written information furnished to the Company by any Underwriter
through Merrill Lynch expressly for use therein.

                  (d) (i) At the time the Company or any person acting on its
behalf (within the meaning, for this clause only, of Rule 163(c) of the 1933 Act
Regulations) made any offer relating to the Shares in reliance on the exemption
of Rule 163 of the 1933 Act Regulations and (ii) at the date hereof, the Company
is a "well-known seasoned issuer" as defined in Rule 405 of the 1933 Act
Regulations ("Rule 405"), including not having been and not being an "ineligible
issuer" as defined in Rule 405.

                  (e) The documents incorporated by reference in the
Registration Statement, the Prospectus or any amendment or supplement thereto,
when they became or become effective under the Securities Act or were or are
filed with the Commission under the Securities Act or the Exchange Act, as the
case may be, conformed or will conform in all material respects with the
requirements of the Securities Act and the Exchange Act, as applicable.

                  (f) The consolidated financial statements of the Company,
together with the related schedules and notes thereto, set forth or included or
incorporated by reference in the Registration Statement, the General Disclosure
Package, and the Prospectus are accurate in all material respects and fairly
present the financial condition of the Company as of the dates indicated and the
results of operations, changes in financial position, stockholders' equity and
cash flows for the periods therein specified are in conformity with generally
accepted accounting principles consistently applied throughout the periods
involved (except as otherwise stated therein). The selected financial and
statistical data included or incorporated by reference in the Registration
Statement, and the Prospectus present fairly the information shown therein and,
to the extent based upon or derived from the financial statements, have been
compiled on a basis consistent with the financial statements presented therein.
No other financial statements are required to be set forth or to be incorporated
by reference in the Registration Statement or the Prospectus under the
Securities Act.

                  (g) The Preliminary Prospectus was, and the Prospectus and the
General Disclosure Package delivered to the Underwriters for use in connection
with this offering will be, identical to the versions of the Preliminary
Prospectus, Prospectus and the General Disclosure Package, respectively, created
to be transmitted to the Commission for filing via EDGAR, except to the extent
permitted by Regulation S-T.

                  (h) The Company has been duly formed and incorporated and is
validly existing as a corporation in good standing under the laws of the State
of Maryland, is duly qualified to do business and is in good standing as a
foreign corporation in each jurisdiction in which its ownership or lease of
property or assets or the conduct of its business requires such qualification,
except where the failure to so qualify would not have a material adverse effect
on the business, assets, properties, prospects, financial condition or results
of operation of the Company taken as a whole (a "Material Adverse Effect"), and
has full corporate power and authority necessary to own, hold, lease and/or
operate its assets and properties, to conduct the business in which it is
engaged and as described in the Prospectus and to enter into and perform



                                      -6-



its obligations under this Agreement and to consummate the transactions
contemplated hereby, and the Company is in compliance in all material respects
with the laws, orders, rules, regulations and directives issued or administered
by such jurisdictions.

                  (i) The Company has no "significant subsidiaries" (as such
term is defined in Rule 1-02 of Regulation S-X promulgated under the Securities
Act) and does not own, directly or indirectly, any shares of stock or any other
equity or long-term debt securities of any corporation or have any equity
interest in any firm, partnership, joint venture, association or other entity,
except for Fixed Income Discount Advisory Company ("FIDAC"). Complete and
correct copies of the articles of incorporation and of the bylaws of the Company
and all amendments thereto have been delivered to Merrill Lynch and, except as
set forth in the exhibits to, or incorporated by reference into, the
Registration Statement, no changes therein will be made subsequent to the date
hereof and prior to the time of purchase or, if applicable, each additional time
of purchase.

                  (j) The Company is not in breach of, or in default under (nor
has any event occurred which with notice, lapse of time, or both would result in
any breach of, or constitute a default under), (i) its articles of incorporation
or bylaws or (ii) any obligation, agreement, covenant or condition contained in
any contract, license, repurchase agreement, indenture, mortgage, deed of trust,
bank loan or credit agreement, note, lease or other evidence of indebtedness, or
any lease, contract or other agreement or instrument to which the Company is a
party or by which it or any of its assets or properties may be bound or
affected, the effect of which breach or default under clause (ii) could have a
Material Adverse Effect. The execution, delivery and performance of this
Agreement, the issuance and sale of the Shares and the consummation of the
transactions contemplated hereby, including the compliance by the Company with
the provisions of the Articles Supplementary, will not conflict with, or result
in any breach of, constitute a default under or a Repayment Event (as defined
below) under (nor constitute any event which with notice, lapse of time, or both
would result in any breach of, constitute a default under or a Repayment Event
under), (i) any provision of the articles of incorporation or bylaws of the
Company, (ii) any provision of any contract, license, repurchase agreement,
indenture, mortgage, deed of trust, bank loan or credit agreement, note, lease
or other evidence of indebtedness, or any lease, contract or other agreement or
instrument to which the Company is a party or by which the Company or any of its
assets or properties may be bound or affected, the effect of which could have a
Material Adverse Effect, or (iii) under any federal, state, local or foreign
law, regulation or rule or any decree, judgment or order applicable to the
Company. As used herein, a "Repayment Event" means any event or condition which
gives the holder of any note, debenture or other evidence of indebtedness (or
any person acting on such holder's behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by the Company
or any subsidiary.

                  (k) As of December 31, 2005, as of the date of this Agreement
and as of the time of purchase, the Company had, has or will have an authorized,
issued and outstanding capitalization as set forth under the headings
"Historical" and "As adjusted for both offerings," respectively, in the section
of the Prospectus Supplement entitled "Capitalization." All of the issued and
outstanding shares of capital stock, including the Series B Preferred Stock in
accordance with the Articles Supplementary, have been duly and validly
authorized and issued and are fully paid and non-assessable, have been issued in
compliance with all federal and state securities laws and were not issued in
violation of any preemptive right, resale right, right of first



                                      -7-



refusal or similar right; the shares of the common stock of the Company, par
value $0.01 (the "Common Stock") issuable upon conversion of the Shares have
been duly and validly authorized and reserved for issuance by the Company and,
when issued and delivered upon conversion and in accordance with the Articles
Supplementary, will be duly and validly issued and fully-paid and non-assessable
and will conform to the description of the Common Stock in the Prospectus.

                  (l) This Agreement has been duly authorized, executed and
delivered by the Company.

                  (m) The capital stock of the Company, including the Shares,
conforms and will conform in all material respects to the description thereof
contained in the Registration Statement, General Disclosure Package and the
Prospectus and such description conforms to the rights set forth in the
instruments defining the same. The certificates for the Shares are in due and
proper form and the holders of the Shares will not be subject to personal
liability by reason of being such holders.

                  (n) The Shares have been duly and validly authorized by the
Company for issuance and sale pursuant to this Agreement and, when issued and
delivered against payment therefor as provided herein, will be duly and validly
issued and fully paid and non-assessable, free and clear of any pledge, lien,
encumbrance, security interest or other claim, and will be registered pursuant
to Section 12 of the Exchange Act.

                  (o) No approval, authorization, consent or order of or filing
with any national, state or local governmental or regulatory commission, board,
body, authority or agency is required in connection with the issuance and sale
of the Shares or the consummation by the Company of the transaction contemplated
hereby, including the issuance of shares of Common Stock upon conversion of the
Shares, other than (i) registration of the Shares under the Securities Act, (ii)
any necessary qualification under the securities or blue sky laws of the various
jurisdictions in which the Shares are being offered by the Underwriters, or
(iii) such approvals as have been obtained in connection with the approval of
the listing of the Common Stock, including the shares of Common Stock issued
upon conversion of the Shares, on NYSE.

                  (p) No person, as such term is defined in Rule 1-02 of
Regulation S-X promulgated under the Securities Act (each, a "Person"), has the
right, contractual or otherwise, to cause the Company to issue to it any shares
of capital stock or other securities of the Company upon the issue and sale of
the Shares to the Underwriters hereunder, nor does any Person have preemptive
rights, co-sale rights, rights of first refusal or other rights to purchase or
subscribe for any of the Shares or any securities or obligations convertible
into or exchangeable for, or any contracts or commitments to issue or sell any
of, the Shares or any options, rights or convertible securities or obligations,
other than those that have been expressly waived prior to the date hereof,
except with respect to shares to be issued and registered in connection with the
Company's acquisition of FIDAC as described in the Registration Statement (the
"FIDAC Shares").

                  (q) Deloitte & Touche LLP (the "Accountants"), whose report on
the consolidated financial statements of the Company is filed with the
Commission as part of the



                                      -8-



Registration Statement and the Prospectus, are and, during the periods covered
by their reports, were independent public accountants as required by the
Securities Act.

                  (r) The Company has all necessary licenses, authorizations,
consents and approvals and has made all necessary filings required under any
federal, state, local or foreign law, regulation or rule, and has obtained all
necessary permits, authorizations, consents and approvals from other Persons, in
order to conduct its business as described in the Prospectus, except as such as
could not have a Material Adverse Effect. The Company is not required by any
applicable law to obtain accreditation or certification from any governmental
agency or authority in order to provide the products and services which it
currently provides or which it proposes to provide as set forth in the
Prospectus. The Company is not in violation of, or in default under, any such
license, permit, authorization, consent or approval or any federal, state, local
or foreign law, regulation or rule or any decree, order or judgment applicable
to the Company, the effect of which could have a Material Adverse Effect.

                  (s) The descriptions in the Registration Statement, the
General Disclosure Package and the Prospectus of the legal or governmental
proceedings, contracts, leases and other legal documents therein described
present fairly the information required to be shown, and there are no legal or
governmental proceedings, contracts, leases, or other documents of a character
required to be described in the Registration Statement, the General Disclosure
Package or the Prospectus or to be filed as exhibits to the Registration
Statement which are not described or filed as required. All agreements between
the Company and third parties expressly referenced in the General Disclosure
Package and Prospectus are legal, valid and binding obligations of the Company
enforceable in accordance with their respective terms, except to the extent
enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting creditors' rights generally and by general
equitable principles.

                  (t) There are no actions, suits, claims, investigations,
inquiries or proceedings pending or, to the best of the Company's knowledge,
threatened to which the Company or any of its officers or directors is a party
or of which any of its properties or other assets is subject at law or in
equity, or before or by any federal, state, local or foreign governmental or
regulatory commission, board, body, authority or agency which could result in a
judgment, decree or order having a Material Adverse Effect.

                  (u) Subsequent to the respective dates as of which information
is given in the Registration Statement, the General Disclosure Package
(including as of the Applicable Time), and the Prospectus, there has not been
(i) any material adverse change, or any development which would reasonably be
expected to cause a material adverse change, in the business, properties or
assets described or referred to in the Registration Statement, the General
Disclosure Package, or the Prospectus, or the results of operations, condition
(financial or otherwise), net worth, business, prospects or operations of the
Company taken as a whole, (ii) any transaction which is material to the Company,
except transactions in the ordinary course of business, (iii) any obligation,
direct or contingent, which is material to the Company taken as a whole,
incurred by the Company, except obligations incurred in the ordinary course of
business, (iv) any change in the capital stock or outstanding indebtedness of
the Company, or (v) except for regular quarterly dividends on the shares of
Series A cumulative redeemable preferred stock, (the "Series A Preferred Stock")
and Common Stock in amounts per share that are consistent with past



                                      -9-



practice, any dividend or distribution of any kind declared, paid or made by the
Company on any class of its capital stock. The Company has no material
contingent obligation which is not disclosed in the Registration Statement, the
General Disclosure Package, or the Prospectus.

                  (v) There are no Persons with registration or other similar
rights to have any equity or debt securities, including securities which are
convertible into or exchangeable for equity securities, registered pursuant to
the Registration Statement or otherwise registered by the Company under the
Securities Act, except with respect to the FIDAC Shares.

                  (w) The Company (i) does not have any issued or outstanding
preferred stock, or other than the Series A Preferred Stock, or (ii) has not
defaulted on any installment on indebtedness for borrowed money or on any rental
on one or more long term leases, which defaults would have a Material Adverse
Effect on the financial position of the Company. The Company has not filed a
report pursuant to Section 13(a) or 15(d) of the Exchange Act since the filing
of its last Annual Report on Form 10-K, indicating that it (i) has failed to pay
any dividend or sinking fund installment on preferred stock or (ii) has
defaulted on any installment on indebtedness for borrowed money or on any rental
on one or more long term leases, which defaults would have a Material Adverse
Effect on the financial position of the Company.

                  (x) Each of the Company and its officers, directors and
controlling Persons has not, directly or indirectly, (i) taken any action
designed to cause or to result in, or that has constituted or which might
reasonably be expected to constitute, the stabilization or manipulation of the
price of the Common Stock to facilitate the sale of the Shares, or (ii) since
the filing of the Registration Statement (except pursuant to the Company's
dividend reinvestment and share purchase plan (the "DRSPP") and in accordance
with the Second Amended and Restated Sales Agency Agreement, dated May 11, 2005,
between the Company and UBS Securities LLC) (A) sold, bid for, purchased, or
paid anyone any compensation for soliciting purchases of, the Shares or (B) paid
or agreed to pay to any Person any compensation for soliciting another to
purchase any other securities of the Company.

                  (y) The shares of Common Stock to be issued upon conversion of
the Shares, have been approved for listing on the NYSE, subject only to official
notice of issuance.

                  (z) Neither the Company nor any of its affiliates (i) is
required to register as a "broker" or "dealer" in accordance with the provisions
of the Exchange Act or (ii) directly or indirectly through one or more
intermediaries, controls or has any other association with (within the meaning
of Article I of the Bylaws of the National Association of Securities Dealers
("NASD")) any member firm of the NASD.

                  (aa) Any certificate signed by any officer of the Company
delivered to Merrill Lynch or to counsel for the Underwriters pursuant to or in
connection with this Agreement shall be deemed a representation and warranty by
the Company to each Underwriter as to the matters covered thereby.

                  (bb) As of the date of this Agreement, the investment
portfolio of the Company (i) consists entirely of (a) mortgage-backed securities
guaranteed, as to payments of principal and interest, by either the Federal Home
Loan Mortgage Corporation, the Federal National Mortgage



                                      -10-



Association or the Government National Mortgage Association and (b) Federal Home
Loan Bank, Federal Home Loan Mortgage Corporation, or Federal National Mortgage
Association debentures and (ii) all of such mortgage-backed securities are REIT
(as defined below) eligible assets. As of the date of this Agreement, the
Company has no plan or intention to materially alter (i) its capital investment
policy or (ii) except in accordance with its capital investment policy, the
percentage of its investment portfolio that is invested in mortgage-backed
securities which are guaranteed, as to payments of principal and interest, by
either the Federal Home Loan Mortgage Corporation, the Federal National Mortgage
Association or the Government National Mortgage Association. The Company has
good and marketable title to all of the properties and assets owned by it, in
each case free and clear of any security interests, liens, encumbrances,
equities, claims and other defects (except for any security interest, lien,
encumbrance or claim that may otherwise exist under any applicable repurchase
agreement), except such as do not have a Material Adverse Effect and do not
interfere with the use made or proposed to be made of such property or asset by
the Company, and except as described in or contemplated by the Prospectus and
the General Disclosure Package. The Company owns no real property. Any real
property and buildings held under lease by the Company are held under valid,
existing and enforceable leases, with such exceptions as are disclosed in the
Prospectus or are not material and do not interfere with the use made or
proposed to be made of such property and buildings by the Company.

                  (cc) The Company has filed all federal, state and foreign
income and franchise tax returns required to be filed on or prior to the date
hereof and has paid taxes shown as due thereon (or that are otherwise due and
payable), other than taxes which are being contested in good faith and for which
adequate reserves have been established in accordance with generally accepted
accounting principles. The Company has no knowledge, after due inquiry, of any
tax deficiency which has been asserted or threatened against the Company. To the
knowledge of the Company, there are no tax returns of the Company that are
currently being audited by federal, state or local taxing authorities or
agencies which would have a Material Adverse Effect.

                  (dd) The Company owns or possesses adequate license or other
rights to use all patents, trademarks, service marks, trade names, copyrights,
software and design licenses, trade secrets, manufacturing processes, other
intangible property rights and know-how (collectively, "Intangibles") necessary
to entitle the Company to conduct its business as described in the Prospectus,
and the Company has not received notice of infringement of or conflict with (and
the Company knows of no such infringement of or conflict with) asserted rights
of others with respect to any Intangibles which could have a Material Adverse
Effect.

                  (ee) The Company maintains a system of internal accounting
controls sufficient to provide reasonable assurance that (i) transactions are
executed in accordance with management's general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles as
applied in the United States and to maintain asset accountability, (iii) access
to assets is permitted only in accordance with management's general or specific
authorization, and (iv) the recorded accountability for assets is compared with
the existing assets at reasonable intervals and appropriate action is taken with
respect to any differences.



                                      -11-



                  (ff) The Company has established and maintains disclosure
controls and procedures (as such term is defined in Rule 13a-14 and 15d-14 under
the Exchange Act); such disclosure controls and procedures are designed to
ensure that material information relating to the Company is made known to the
Company's Chief Executive Officer and its Chief Financial Officer, and such
disclosure controls and procedures are effective to perform the functions for
which they were established; any significant material weaknesses in internal
controls have been identified for the Company's Chief Executive Officer and its
Chief Financial Officer; and since the date of the most recent evaluation of
such disclosure controls and procedures, there have been no significant changes
in internal controls or in other factors that could significantly affect
internal controls.

                  (gg) The Company is insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as
are prudent and customary in the business in which it is engaged. The Company
has no reason to believe that it will not be able to renew its existing
insurance coverage as and when such coverage expires or to obtain similar
coverage from similar insurers as may be necessary to continue its business at a
cost that would not have a Material Adverse Effect.

                  (hh) The Company is not in violation, and has not received
notice of any violation with respect to, any applicable environmental, safety or
similar law applicable to the business of the Company. The Company has received
all permits, licenses or other approvals required of them under applicable
federal and state occupational safety and health and environmental laws and
regulations to conduct its business, and the Company is in compliance with all
terms and conditions of any such permit, license or approval, except any such
violation of law or regulation, failure to receive required permits, licenses or
other approvals or failure to comply with the terms and conditions of such
permits, licenses or approvals which could not, singly or in the aggregate, have
a Material Adverse Effect.

                  (ii) The Company has not incurred any liability for any
finder's fees or similar payments in connection with the transactions herein
contemplated, except as may otherwise exist with respect to the Underwriters
pursuant to this Agreement.

                  (jj) There are no existing or threatened labor disputes with
the employees of the Company which are likely to have individually or in the
aggregate a Material Adverse Effect.

                  (kk) Neither the Company nor, to the knowledge of the Company,
any employee or agent of the Company, has made any payment of funds of the
Company or received or retained any funds in violation of any law, rule or
regulation or of a character required to be disclosed in the Prospectus. No
relationship, direct or indirect, exists between or among the Company, on the
one hand, and the directors, officers and stockholders of the Company, on the
other hand, which is required by the Securities Act to be described in the
Registration Statement and the Prospectus that is not so described.

                  (ll) The Company, since its date of inception, has been, and
upon the sale of the Shares will continue to be, organized and operated in
conformity with the requirements for qualification and taxation as a "real
estate investment trust" (a "REIT") under Sections 856 through 860 of the
Internal Revenue Code of 1986, as amended (the "Code"), for all taxable



                                      -12-



years commencing with its taxable year ended December 31, 1997. The proposed
method of operation of the Company as described in the Prospectus will enable
the Company to continue to meet the requirements for qualification and taxation
as a REIT under the Code, and no actions have been taken (or not taken which are
required to be taken) which would cause such qualification to be lost. The
Company intends to continue to operate in a manner which would permit it to
qualify as a REIT under the Code. The Company has no intention of changing its
operations or engaging in activities which would cause it to fail to qualify, or
make economically undesirable its continued qualification, as a REIT.

                  (mm) The Company is not and, after giving effect to the
offering and sale of the Shares, will not be an "investment company" or an
entity "controlled" by an "investment company," as such terms are defined in the
Investment Company Act of 1940, as amended (the "Investment Company Act").

                  (nn) No relationship, direct or indirect, exists between or
among the Company, on the one hand, and the directors, officers, stockholders or
directors of the Company, on the other hand, which is required by the rules of
the NASD to be described in the Registration Statement and the Prospectus which
is not so described.

                  (oo) The Company has not, directly or indirectly, including
through any subsidiary, extended credit, arranged to extend credit, or renewed
any extension of credit, in the form of a personal loan, to or for any director
or executive officer of the Company, or to or for any family member or affiliate
of any director or executive officer of the Company.

                  (pp) Neither the Company nor any of the subsidiaries nor, to
the Company's knowledge, any employee or agent of the Company or the
subsidiaries has made any payment of funds of the Company or the subsidiaries or
received or retained any funds in violation of any law, rule or regulation,
which payment, receipt or retention of funds is of a character required to be
disclosed in the Registration Statement or the Prospectus.

                  (qq) The Company is in compliance with all presently
applicable provisions of the Sarbanes-Oxley Act of 2002 and the rules and
regulations promulgated thereunder (the "Sarbanes-Oxley Act") and is actively
taking steps to ensure that it will be in compliance with other applicable
provisions of the Sarbanes-Oxley Act upon the effectiveness of such provisions.

                  (rr) The Registration Statement is not the subject of a
pending proceeding or examination under Section 8(d) or 8(e) of the Securities
Act, and the Company is not the subject of a pending proceeding under Section 8A
of the Securities Act in connection with the offering of the Shares.

                  4. CERTAIN COVENANTS OF THE COMPANY. The Company hereby
covenants and agrees with each of the Underwriters that:

                  (a) The Company will furnish such information as may be
required and otherwise will cooperate in qualifying the Shares and the shares of
Common Stock issued upon conversion of the Shares for offering and sale under
the securities or blue sky laws of such jurisdictions (both domestic and
foreign) as Merrill Lynch may designate and to maintain such qualifications in
effect so long as required for the distribution of the Shares, provided that the



                                      -13-



Company shall not be required to qualify as a foreign corporation or to consent
to the service of process under the laws of any such jurisdiction (except
service of process with respect to the offering and sale of the Shares). The
Company will promptly advise Merrill Lynch of the receipt by the Company of any
notification with respect to the suspension of the qualification of the Shares
and the shares of Common Stock to be issued upon conversion of the Shares for
sale in any jurisdiction or the initiation or threatening of any proceeding for
such purpose.

                  (b) The Company will prepare the Prospectus in a form in
compliance with Rule 430(A) and approved by the Underwriters and file such
Prospectus with the Commission pursuant to Rule 424(b) under the Securities Act
not later than 10:00 A.M. (New York City time), on or before the second Business
Day following the date of this Agreement or on such other day as the parties may
mutually agree and to furnish promptly (and with respect to the initial delivery
of such Prospectus, not later than 10:00 A.M. (New York City time) on or before
the second Business Day following the date of this Agreement or on such other
day as the parties may mutually agree) to the Underwriters copies of the
Prospectus (or of the Prospectus as amended or supplemented if the Company shall
have made any amendments or supplements thereto after the effective date of the
Registration Statement) in such quantities and at such locations as the
Underwriters may reasonably request for the purposes contemplated by the
Securities Act, which the Prospectus and any amendments or supplements thereto
furnished to the Underwriters will be identical to the version created to be
transmitted to the Commission for filing via EDGAR, except to the extent
permitted by Regulation S-T. The Company will prepare a final term sheet (the
"Final Term Sheet") reflecting the final terms of the Shares, in form and
substance satisfactory to Merrill Lynch, and shall file such Final Term Sheet as
an "issuer free writing prospectus" pursuant to Rule 433 as soon as practicable
following the execution of this Agreement; provided that the Company shall
furnish Merrill Lynch with copies of any such Final Term Sheet a reasonable
amount of time prior to such proposed filing and will not use or file any such
document to which Merrill Lynch or counsel to the Underwriters shall object in
writing.

                  (c) The Company will advise Merrill Lynch immediately,
confirming such advice in writing, of (i) the receipt of any comments from the
Commission relating to any filing of the Company under the Securities Act or the
Exchange Act, (ii) any request by the Commission for amendments or supplements
to the Registration Statement or the Prospectus or for additional information
with respect thereto, (iii) the issuance by the Commission of any stop order
suspending the effectiveness of the Registration Statement or of any order
preventing or suspending the use of any Preliminary Prospectus or the Prospectus
or of any examination pursuant to Section 8(e) of the Securities Act concerning
the Registration Statement, (iv) the suspension of the qualification of the
Shares or the shares of Common Stock to be issued upon conversion of the Shares
for offering or sale in any jurisdiction, (v) the initiation, threatening or
contemplation of any proceedings for any of such purposes and, if the Commission
or any other governmental agency or authority should issue any such order, the
Company will make every reasonable effort to obtain the lifting or removal of
such order as soon as possible. The Company will advise Merrill Lynch promptly
of any proposal to amend or supplement the Registration Statement or the
Prospectus including by filing any documents that would be incorporated therein
by reference, and will furnish Merrill Lynch with copies of any such documents a
reasonable amount of time prior to such proposed filing or use, as the case may
be, and will not file or use any such document to which Merrill Lynch or counsel
for the Underwriters shall object in writing. The Company has given Merrill
Lynch notice of any filings



                                      -14-



made pursuant to the 1934 Act or 1934 Act Regulations within 48 hours prior to
the Applicable Time; the Company will give Merrill Lynch notice of its intention
to make any such filing from the Applicable Time to the time of purchase and, if
applicable, each additional time of purchase, and will furnish the Merrill Lynch
with copies of any such documents a reasonable amount of time prior to such
proposed filing, as the case may be, and will not file or use any such document
to which the Merrill Lynch or counsel for the Underwriters shall object in
writing.

                  (d) The Company will advise Merrill Lynch promptly and, if
requested by Merrill Lynch, will confirm such advice in writing when any
post-effective amendment to the Registration Statement becomes effective under
the Securities Act.

                  (e) The Company will furnish to Merrill Lynch and, upon
request, to each of the other Underwriters for a period of five years from the
date of this Agreement (i) copies of any reports or other communications which
the Company shall send to its stockholders or shall from time to time publish or
publicly disseminate, (ii) copies of all annual, quarterly and current reports
filed with the Commission on Forms 10-K, 10-Q and 8-K, or such other similar
form as may be designated by the Commission, (iii) copies of documents or
reports filed with any national securities exchange on which any class of
securities of the Company is listed, and (iv) such other information as Merrill
Lynch may reasonably request regarding the Company, in each case as soon as such
communications, documents or information become available.

                  (f) The Company will advise the Underwriters promptly of the
happening of any event known to the Company within the time during which a
Prospectus relating to the Shares is required to be delivered under the
Securities Act which would require the making of any change in the Prospectus
then being used, or in the information incorporated by reference therein, so
that the Prospectus would not include an untrue statement of material fact or
omit to state a material fact required to be stated therein or necessary to make
the statements therein, in the light of the circumstances under which they were
made, not misleading, or if it is necessary at any time to amend or supplement
the Prospectus to comply with any law. If within the time during which a
Prospectus relating to the Shares is required to be delivered under the
Securities Act any event shall occur or condition shall exist which, in the
reasonable opinion of the Company, Merrill Lynch or their respective counsel,
would require the making of any change in the Prospectus then being used, or in
the information incorporated by reference therein, so that the Prospectus would
not include an untrue statement of material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading, or
if it is necessary at any time to amend or supplement the Prospectus to comply
with any law, the Company will promptly prepare and furnish to the Underwriters
copies of the proposed amendment or supplement before filing any such amendment
or supplement with the Commission and thereafter promptly furnish, at the
Company's own expense, to the Underwriters and to dealers copies in such
quantities and at such locations as Merrill Lynch may from time to time
reasonably request of an appropriate amendment to the Registration Statement or
supplement to the Prospectus so that the Prospectus as so amended or
supplemented will not, in the circumstances when it is so delivered, be
misleading or so that the Prospectus will comply with the law. If at any time
following issuance of an Issuer Free Writing Prospectus there occurred or occurs
an event or development as a result of which such Issuer Free Writing Prospectus
conflicted or would conflict with the information contained in the Registration
Statement relating to the Shares or the Statutory Prospectus or any


                                      -15-




preliminary prospectus or included or would include an untrue statement of a
material fact or omitted or would omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances,
prevailing at that subsequent time, not misleading, the Company will promptly
notify Merrill Lynch and will promptly amend or supplement, at its own expense,
such Issuer Free Writing Prospectus to eliminate or correct such conflict,
untrue statement or omission.

                  (g) The Company will make generally available to its
stockholders as soon as practicable, and in the manner contemplated by Rule 158
of the Securities Act but in any event not later than 15 months after the end of
the Company's current fiscal quarter, an earnings statement (which need not be
audited) covering a 12-month period beginning after the date upon which the
Prospectus Supplement is filed pursuant to Rule 424(b) under the Securities Act
that shall satisfy the provisions of Section 11(a) of the Securities Act and
Rule 158 thereunder and will advise the Underwriters in writing when such
statement has been made available.

                  (h) The Company will furnish to Merrill Lynch a signed copy of
the Registration Statement, as initially filed with the Commission, and of all
amendments thereto (including all exhibits thereto and documents incorporated by
reference therein) and such number of conformed copies of the foregoing (other
than exhibits) as Merrill Lynch may reasonably request.

                  (i) The Company will apply the net proceeds from the sale of
the Shares in the manner set forth under the caption "Use of Proceeds" in the
Prospectus.

                  (j) The Company will furnish to Merrill Lynch, not less than
two Business Days before a filing with the Commission during the period referred
to in paragraph (f) above, a copy of any document proposed to be filed pursuant
to Section 13, 14 or 15(d) of the Exchange Act and during such period will file
all such documents in a manner and within the time periods required by the
Exchange Act.

                  (k) The Company will not sell, offer, contract to sell,
pledge, register, grant any option to purchase or otherwise dispose of, directly
or indirectly, any shares of capital stock, or any securities convertible into,
or exercisable, exchangeable or redeemable for shares of capital stock, except
for the registration of the Shares, the Common Stock offered in connection with
that certain Underwriting Agreement, dated as of the date hereof, between the
Company, Merrill Lynch and other underwriters (the "Common Stock Underwriting
Agreement") and the Common Stock that the Series B Preferred Stock is
convertible into, and the sales to the Underwriters pursuant to this Agreement
and the Common Stock Underwriting Agreement and except for issuances of Common
Stock upon the exercise of outstanding options, for a period of 90 days after
the date hereof, without the prior written consent of Merrill Lynch. The
foregoing sentence shall not apply to (i) the Shares to be sold hereunder, (ii)
any shares of Common Stock issued by the Company upon the exercise of an option
outstanding on the date hereof and referred to in the Prospectus, (iii) shares
of Common Stock issued pursuant to the DRSPP, (iv) the grant of awards pursuant
to the Company's Long-Term Stock Incentive Plan or issuances pursuant to the
exercise of employee stock options or other awards or (v) with respect to any
FIDAC Shares. Notwithstanding the foregoing, if (1) during the last 17 days of
the 90-day restricted period the Company issues an earnings release or material
news or a material event



                                      -16-



relating to the Company occurs or (2) prior to the expiration of the 90-day
restricted period, the Company announces that it will release earnings results
or becomes aware that material news or a material event will occur during the
16-day period beginning on the last day of the 90-day restricted period, the
restrictions imposed in this paragraph (k) shall continue to apply until the
expiration of the 18-day period beginning on the issuance of the earnings
release or the occurrence of the material news or material event.

                  (l) The Company will use its best efforts to cause each
officer and director of the Company to furnish to Merrill Lynch, prior to the
time of purchase, a letter or letters, substantially in the form of Exhibit D
hereto, pursuant to which each such person shall agree, subject to certain
exceptions set forth therein, not to sell, offer, contract to sell, pledge,
grant any option to purchase or otherwise dispose of, directly or indirectly,
any shares of capital stock, or any securities convertible into, or exercisable,
exchangeable or redeemable for shares of capital stock of the Company for a
period of 90 days after the date hereof, without the prior written consent of
Merrill Lynch.

                  (m) The Company will use its best efforts to cause the shares
of Common Stock, including the shares of Common Stock to be issued upon
conversion of the Shares, to be listed on the NYSE and to maintain such listing
and to file with the NYSE all documents and notices required by the NYSE of
companies that have securities that are listed on the NYSE.

                  (n) The Company will reserve and keep available at all times,
free of preemptive rights, a sufficient number of shares of the Common Stock for
the purpose of enabling the Company to satisfy any obligation to issue shares of
the Common Stock upon conversion of the Shares;

                  (o) The Company will maintain and keep accurate books and
records reflecting their assets and maintain internal accounting controls which
provide reasonable assurance that (i) transactions are executed in accordance
with management's authorization, (ii) transactions are recorded as necessary to
permit the preparation of the Company's consolidated financial statements and to
maintain accountability for the assets of the Company, (iii) access to the
assets of the Company is permitted only in accordance with management's
authorization and (iv) the recorded accounts of the assets of the Company are
compared with existing assets at reasonable intervals.

                  (p) The Company will engage and maintain, at its expense, a
registrar and transfer agent for the Shares and the shares of Common Stock to be
issued upon conversion of the Shares.

                  (q) The Company will pay all expenses, fees and taxes (other
than any transfer taxes and fees and disbursements of counsel for the
Underwriters, except as set forth under Section 5 hereof or (iii) or (iv) below)
in connection with (i) the preparation and filing of the Registration Statement,
each Preliminary Prospectus, the Prospectus, any Permitted Free Writing
Prospectus and any amendments or supplements thereto, and the printing and
furnishing of copies of each thereof to the Underwriters and to dealers
(including costs of mailing and shipment), (ii) the issuance, sale and delivery
of the Shares and the shares of Common Stock to be issued upon conversion of the
Shares by the Company, (iii) the word processing and/or



                                      -17-



printing of this Agreement, any Agreement among the Underwriters, any dealer
agreements, and the reproduction and/or printing and furnishing of copies of
each thereof to the Underwriters and to dealers (including costs of mailing and
shipment), (iv) the costs and expenses of the Company relating to investor
presentations on any "road show" undertaken in connection with the marketing of
the Shares (including the shares of Common Stock issuable upon conversion of the
Shares), including without limitation, expenses associated with the production
of road show slides and graphics, fees and expenses of any consultants engaged
in connection with the road show presentations, travel and lodging expenses of
the representatives and officers of the Company and any such consultants, and
the cost of aircraft and other transportation chartered in connection with the
road show, except that the lodging, airfare (except if the Company charters a
flight in which case employees of the Underwriters ride on such charter without
charge), and incidental expenses of employees of the Underwriters shall be the
responsibility of the Underwriters, (v) the qualification of the Shares and the
shares of Common Stock to be issued upon conversion of the Shares for offering
and sale under state laws and the determination of their eligibility for
investment under state law as aforesaid (including the legal fees and filing
fees and other disbursements of counsel to the Underwriters) and the
preparation, printing and furnishing of copies of any blue sky surveys or legal
investment surveys to the Underwriters and to dealers, (vi) any listing of the
Common Stock, including the shares of Common Stock to be issued upon conversion
of the Shares, on the NYSE and any registration thereof under the Exchange Act,
(vii) the filing, if any, for review of the public offering of the Shares and
the shares of Common Stock to be issued upon conversion of the Shares by the
NASD, (viii) the performance of the Company's other obligations hereunder, and
(ix) the costs and expenses (including without limitation any damages or other
amounts payable in connection with legal or contractual liability) associated
with the reforming of any contracts for sale of the Shares and the shares of
Common Stock to be issued upon conversion of the Shares made by the Underwriters
caused by a breach of the representation contained in the first paragraph of
Section 3(c).

                  (r) The Company will not (i) take, directly or indirectly,
prior to termination of the underwriting syndicate contemplated by this
Agreement, any action designed to stabilize or manipulate the price of any
security of the Company, or which may cause or result in, or which might in the
future reasonably be expected to cause or result in, the stabilization or
manipulation of the price of any security of the Company, to facilitate the sale
or resale of any of the Shares, (ii) sell, bid for, purchase or pay any Person
(other than as contemplated by the provisions hereof) any compensation for
soliciting purchases of the Shares, or (iii) pay or agree to pay to any Person
any compensation for soliciting any order to purchase any other securities of
the Company.

                  (s) The Company will not invest in futures contracts, options
on futures contracts or options on commodities unless the Company is exempt from
the registration requirements of the Commodity Exchange Act, as amended, or
otherwise complies with the Commodity Exchange Act, as amended. In addition, the
Company will not engage in any activities which might be subject to the
Commodity Exchange Act, as amended, unless such activities are exempt from that
Act or otherwise comply with that Act or with an applicable no-action letter to
the Company from the Commodities Futures Trading Commission.

                  (t) The Company will comply with all of the provisions of any
undertakings in the Registration Statement.



                                      -18-



                  (u) The Company has been organized and operated in conformity
with the requirements for qualification and taxation of the Company as a REIT
under the Code, and the Company's proposed methods of operation will enable the
Company to continue to meet the requirements for qualification and taxation as a
REIT under the Code for subsequent taxable years.

                  (v) The Company will not be or become, at any time prior to
the expiration of three years after the date of the Agreement, an "investment
company," as such term is defined in the Investment Company Act.

                  (w) The Company has retained the Accountants as its qualified
accountants and qualified tax experts (i) to test procedures and conduct annual
compliance reviews designed to determine compliance with the REIT provisions of
the Code and the Company's exempt status under the Investment Company Act and
(ii) to otherwise assist the Company in monitoring appropriate accounting
systems and procedures designed to determine compliance with the REIT provisions
of the Code and the Company's exempt status under the Investment Company Act.

                  (x) The Company will comply with all requirements imposed upon
it by the Securities Act and the Exchange Act as from time to time in force, so
far as necessary to permit the continuance of sales of, or dealings in, the
Shares and the shares of Common Stock to be issued upon conversion of the
Shares, as contemplated by the provisions hereof and the Prospectus.

                  (y) The Company will maintain such controls and other
procedures, including, without limitation, those required by Sections 302 and
906 of the Sarbanes-Oxley Act, and the applicable regulations thereunder that
are designed to ensure that information required to be disclosed by the Company
in the reports that it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the
Commission's rules and forms, including, without limitation, controls and
procedures designed to ensure that information required to be disclosed by the
Company in the reports that it files or submits under the Exchange Act is
accumulated and communicated to the Company's management, including its chief
executive officer and chief financial officer, or persons performing similar
functions, as appropriate to allow timely decisions regarding required
disclosure and to ensure that material information relating to the Company is
made known to them by others within those entities, particularly during the
period in which such periodic reports are being prepared.

                  (z) The Company will comply with all effective applicable
provisions of the Sarbanes-Oxley Act.

                  (aa) The Company represents and agrees that, unless it obtains
the prior consent of Merrill Lynch, and each Underwriter represents and agrees
that, unless it obtains the prior consent of the Company and Merrill Lynch, it
has not made and will not make any offer relating to the Shares that would
constitute an "issuer free writing prospectus," as defined in Rule 433, or that
would otherwise constitute a "free writing prospectus," as defined in Rule 405,
required to be filed with the Commission or, in the case of the Company, whether
or not required to be filed with the Commission; provided, however, that prior
to the preparation of the Final



                                      -19-



Term Sheet in accordance with Section 4(b), the Underwriters are authorized to
use the information with respect to the final terms of the Shares in
communications conveying information relating to the offering to investors. Any
such free writing prospectus consented to by the Company and Merrill Lynch is
hereinafter referred to as a "Permitted Free Writing Prospectus." The Company
represents that it has treated or agrees that it will treat each Permitted Free
Writing Prospectus as an "issuer free writing prospectus," as defined in Rule
433, and has complied and will comply with the requirements of Rule 433
applicable to any Permitted Free Writing Prospectus, including timely filing
with the Commission where required, legending and record keeping.

                  5. REIMBURSEMENT OF UNDERWRITERS' EXPENSES. If the Shares are
not delivered for any reason other than the termination of this Agreement
pursuant to the default by one or more of the Underwriters in its or their
respective obligations hereunder, the Company shall, in addition to paying the
amounts described in Section 4(q) hereof, reimburse the Underwriters for all of
their out-of-pocket expenses, including the fees and disbursements of their
counsel.

                  6. CONDITIONS OF UNDERWRITERS' OBLIGATIONS. The several
obligations of the Underwriters hereunder are subject to the accuracy of the
representations and warranties on the part of the Company on the date hereof, at
the Applicable Time and at the time of purchase (and the several obligations of
the Underwriters at each additional time of purchase are subject to the accuracy
of the representations and warranties on the part of the Company on the date
hereof, at the Applicable Time and at the time of purchase (unless previously
waived) and at each additional time of purchase, as the case may be), the
performance by the Company of its obligations hereunder and to the following
additional conditions precedent:

                  (a) The Company shall furnish to Merrill Lynch at the time of
purchase and at each additional time of purchase, as the case may be, opinions
of Kirkpatrick & Lockhart Nicholson Graham LLP and McKee Nelson LLP, each
counsel for the Company, addressed to the Underwriters, and dated the time of
purchase or each additional time of purchase, as the case may be, with
reproduced copies for each of the other Underwriters and in form satisfactory to
Fried Frank Harris Shriver & Jacobson LLP, counsel for the Underwriters,
substantially in the form of Exhibit B and Exhibit C, respectively attached
hereto.

                  (b) Merrill Lynch shall have received from the Accountants,
letters dated, respectively, the date of this Agreement and the time of purchase
and each additional time of purchase, as the case may be, and addressed to the
Underwriters (with reproduced copies for each of the Underwriters) in the forms
heretofore approved by Merrill Lynch relating to the financial statements,
including any pro forma financial statements of the Company and such other
matters customarily covered by comfort letters issued in connection with a
registered public offering.

                  In the event that the letters referred to above set forth any
such changes, decreases or increases, it shall be a further condition to the
obligations of the Underwriters that (i) such letters shall be accompanied by a
written explanation of the Company as to the significance thereof, unless
Merrill Lynch deem such explanation unnecessary, and (ii) such changes,
decreases or increases do not, in the sole judgment of Merrill Lynch, make it
impractical or



                                      -20-



inadvisable to proceed with the purchase and delivery of the Shares as
contemplated by the Registration Statement and the Prospectus.

                  (c) Merrill Lynch shall have received at the time of purchase
and at each additional time of purchase, as the case may be, the favorable
opinion of Fried Frank Harris Shriver & Jacobson LLP, counsel for the
Underwriters, dated the time of purchase or each additional time of purchase, as
the case may be.

                  (d) No amendment or supplement to the Registration Statement
or the Prospectus, including documents deemed to be incorporated by reference
therein, or Issuer Free Writing Prospectus shall be filed to which the
Underwriters object in writing.

                  (e) Prior to the time of purchase or each additional time of
purchase, as the case may be, (i) no stop order with respect to the
effectiveness of any one of the Registration Statement shall have been issued
under the Securities Act or proceedings initiated under Section 8(d) or 8(e) of
the Securities Act; (ii) the Registration Statement and all amendments thereto,
or modifications thereof, if any, shall not contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading; and (iii) the
Prospectus and all amendments or supplements thereto, or modifications thereof,
if any, and the General Disclosure Package shall not contain an untrue statement
of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein, in the light of the
circumstances under which they are made, not misleading.

                  (f) All filings with the Commission required by Rule 424 under
the Securities Act to have been filed by the time of purchase or each additional
time of purchase, as the case may be, shall have been made within the applicable
time period prescribed for such filing by Rule 424 (without reliance on Rule
424(b)(8)). A prospectus containing the Rule 430(A) information shall have been
filed with the Commission in accordance with Rule 424(b) (or a post effective
amendment providing such information shall have been filed and declared
effective in accordance with the requirements of Rule 430(A)).

                  (g) Between the time of execution of this Agreement and the
time of purchase or each additional time of purchase, as the case may be, (i) no
material and unfavorable change, financial or otherwise (other than as referred
to in the Registration Statement, and the Prospectus and the General Disclosure
Package, in each case as of the Applicable Time), in the business, condition,
net worth or prospects of the Company shall occur or become known and (ii) no
transaction which is material and unfavorable to the Company shall have been
entered into by the Company.

                  (h) The Company will, at the time of purchase or each
additional time of purchase, as the case may be, deliver to Merrill Lynch a
certificate of two of its executive officers to the effect that the
representations and warranties of the Company as set forth in this Agreement are
true and correct as of each such date, that the Company shall perform such of
its obligations under this Agreement as are to be performed at or before the
time of purchase and at or before each additional time of purchase, as the case
may be, and that the conditions set forth in paragraphs (e) and (g) of this
Section 6 have been met.



                                      -21-



                  (i) The Company shall have furnished to Merrill Lynch such
other documents and certificates as to the accuracy and completeness of any
statement in the Registration Statement and the Prospectus as of the time of
purchase and each additional time of purchase, as the case may be, as Merrill
Lynch may reasonably request.

                  (j) The shares of Common Stock to be issued upon conversion of
the Shares, shall have been approved for listing on the NYSE, subject only to
notice of issuance at or prior to the time of purchase or each additional time
of purchase, as the case may be.

                  (k) The NASD shall not have raised any objection with respect
to the fairness and reasonableness of the underwriting terms and arrangements.

                  (l) Merrill Lynch shall have received lock-up agreements from
the Company and its officers and directors, in the form of Exhibit D attached
hereto, and such letter agreements shall be in full force and effect.

                  (m) Between the time of execution of this Agreement and the
time of purchase or each additional time of purchase, as the case may be, there
shall not have occurred any downgrading, nor shall any notice or announcement
have been given or made of (i) any intended or potential downgrading or (ii) any
review or possible change that does not indicate an improvement, in the rating
accorded any securities of or guaranteed by the Company by any "nationally
recognized statistical rating organization," as that term is defined in Rule
436(g)(2) under the Securities Act.

                  7. TERMINATION. The obligations of the several Underwriters
hereunder shall be subject to termination in the absolute discretion of Merrill
Lynch, at any time prior to the time of purchase or, if applicable, each
additional time of purchase, (i) if any of the conditions specified in Section 6
shall not have been fulfilled when and as required by this Agreement to be
fulfilled, (ii) if any material adverse and unfavorable change occurs (financial
or otherwise), or any development involving a material adverse and unfavorable
change occurs (financial or otherwise) (in each case, other than as disclosed
in, or incorporated by reference into, the Registration Statement, the General
Disclosure Package, and the Prospectus as of the Applicable Time (exclusive of
any supplement thereto)), in the operations, business, net worth, condition or
prospects of the Company, or a material change in management of the Company
occurs, whether or not arising in the ordinary course of business, which would,
in the sole judgment of Merrill Lynch, make it impracticable to market the
Shares, (iii) if (a) the United States shall have declared war in accordance
with its constitutional processes or there has occurred an outbreak or
escalation of hostilities or other national or international calamity or crisis
or change or development in economic, political or other conditions the effect
of which on, or (b) any material adverse change in the financial markets of the
United States or the international financial markets is such as to make it, in
the sole judgment of Merrill Lynch, impracticable or inadvisable to market the
Shares or enforce contracts for the sale of the Shares, (iv) if trading in any
securities of the Company has been suspended or materially limited by the
Commission or by the NYSE, or if trading generally on the NYSE, American Stock
Exchange or in the Nasdaq National Market has been suspended, materially
limited, (including an automatic halt in trading pursuant to market-decline
triggers other than those in which solely program trading is temporarily
halted), or limitations on or minimum prices for trading (other than limitations
on hours or



                                      -22-



numbers of days of trading) shall have been fixed, or maximum ranges for prices
for securities have been required, by such exchange or the NASD or Nasdaq or by
order of the Commission or any other governmental authority, (v) if a banking
moratorium shall have been declared by New York or United States authorities or
a material disruption has occurred in commercial banking or securities
settlement or clearance services in the United States, (vi) if there shall have
occurred any downgrading, or any notice or announcement shall have been given or
made of (a) any intended or potential downgrading or (b) any review or possible
change that does not indicate an improvement, in the rating accorded any
securities of or guaranteed by the Company by any "nationally recognized
statistical rating organization," as that term is defined in Rule 436(g)(2)
under the Securities Act, (vii) if any federal or state statute, regulation,
rule or order of any court or other governmental authority has been enacted,
published, decreed or otherwise promulgated which, in the reasonable opinion of
Merrill Lynch, materially adversely affects or will materially adversely affect
the business or operations of the Company, or (viii) if any action has been
taken by any federal, state or local government or agency in respect of its
monetary or fiscal affairs which, in the reasonable opinion of Merrill Lynch,
has a material adverse effect on the securities markets in the United States.

                  If Merrill Lynch elects to terminate this Agreement as
provided in this Section 7, the Company and each other Underwriter shall be
notified promptly by telephone, which shall be promptly confirmed by facsimile.

                  If the sale to the Underwriters of the Shares, as contemplated
by this Agreement, is not carried out by the Underwriters for any reason
permitted under this Agreement or if such sale is not carried out because the
Company shall be unable to comply with any of the terms of this Agreement, the
Company shall not be under any obligation or liability under this Agreement
(except to the extent provided in Sections 3, 4(p), 5 and 9 hereof), and the
Underwriters shall be under no obligation or liability to the Company under this
Agreement (except to the extent provided in Section 9 hereof) or to one another
hereunder.

                  8. INCREASE IN UNDERWRITERS' COMMITMENTS. If any Underwriter
shall default in its obligation under this Agreement to take up and pay for the
Shares to be purchased by it under this Agreement (otherwise than for reasons
sufficient to justify the termination of this Agreement under the provisions of
Section 7 hereof), Merrill Lynch shall have the right, within 36 hours after
such default, to make arrangements for one or more of the non-defaulting
Underwriters, or any other underwriters, to purchase all, but not less than all,
of the Shares which such Underwriter shall have agreed but failed to take up and
pay for (the "Defaulted Shares"). Absent the completion of such arrangements
within such 36 hour period, (i) if the total number of Defaulted Shares does not
exceed 10% of the total number of Shares to be purchased at the time of purchase
or each additional time of purchase, as the case may be, each non-defaulting
Underwriter shall take up and pay for (in addition to the number of Shares which
it is otherwise obligated to purchase on such date pursuant to this Agreement)
the number of Shares agreed to be purchased by all such defaulting Underwriters
in such amount or amounts as Merrill Lynch may designate with the consent of
each Underwriter so designated or, in the event no such designation is made,
such Shares shall be taken up and paid for by all non-defaulting Underwriters
pro rata in proportion to the aggregate number of Firm Shares set opposite the
names of such non-defaulting Underwriters in Schedule A; and (ii) if the total
number of Defaulted Shares exceeds 10% of such total number of Shares to be
purchased at the time of



                                      -23-



purchase or each additional time of purchase, as the case may be, and if neither
the non-defaulting Underwriters nor the Company shall make arrangements within
the five Business Day period from the date of default for the purchase of such
Defaulted Shares, Merrill Lynch may terminate this Agreement by notice to the
Company, without liability of any party to any other party except that the
provisions of Sections 3 4(p), 5 and 9 shall at all times be effective and shall
survive such termination. Nothing in this paragraph, and no action taken
hereunder, shall relieve any defaulting Underwriter from liability in respect of
any default of such Underwriter under this Agreement.

                  Without relieving any defaulting Underwriter from its
obligations hereunder, the Company agrees with the non-defaulting Underwriters
that they will not sell any Shares hereunder unless all of the Shares are
purchased by the Underwriters (or by substituted Underwriters selected by
Merrill Lynch with the approval of the Company or selected by the Company with
Merrill Lynch' approval).

                  If a new Underwriter or Underwriters are substituted for a
defaulting Underwriter or Underwriters in accordance with the foregoing
provisions, the Company or Merrill Lynch shall have the right to postpone the
time of purchase or each additional time of purchase, as the case may be, for a
period not exceeding seven Business Days from the date of substitution in order
that any necessary changes in the Registration Statement and the Prospectus and
other documents may be effected.

                  The term Underwriter as used in this Agreement shall refer to
and include any Underwriter substituted under this Section 8 with like effect as
if such substituted Underwriter had originally been named in Schedule A.

                  9. INDEMNITY AND CONTRIBUTION.

                  (a) The Company agrees to indemnify, defend and hold harmless
each Underwriter, its partners, directors and officers, and any Person who
controls any Underwriter within the meaning of Section 15 of the Securities Act
or Section 20 of the Exchange Act, and the successors and assigns of all of the
foregoing Persons from and against any loss, damage, expense, liability or claim
(including, but not limited to, the reasonable cost of investigation) which,
jointly or severally, any such Underwriter or any such Person may incur under
the Securities Act, the Exchange Act, federal or state statutory law or
regulation, the common law or otherwise, insofar as such loss, damage, expense,
liability or claim arises out of or is based upon (i) any untrue statement or
alleged untrue statement of a material fact contained in the Registration
Statement (or in the Registration Statement as amended by any post-effective
amendment thereof by the Company and including the Rule 430A Information) or in
a Prospectus (the term Prospectus for the purpose of this Section 9 being deemed
to include any Preliminary Prospectus, the Prospectus and the Prospectus as
amended or supplemented by the Company) or in any Issuer Free Writing
Prospectus, or in any documents filed under the Exchange Act and deemed to be
incorporated by reference into the Prospectus, or in any application or other
document executed by or on behalf of the Company or based on written information
furnished by or on behalf of the Company filed in any jurisdiction in order to
qualify the Shares under the securities or blue sky laws thereof or filed with
the Commission, (ii) upon any omission or alleged omission to state in any such
document a material fact required to be



                                      -24-



stated therein or necessary to make the statements made therein, in the light of
the circumstances under which they were made, not misleading or (iii) any act or
failure to act or any alleged act or failure to act by the Underwriters in
connection with, or relating in any manner to, the Shares or the offering
contemplated hereby, and which is included as part of or referred to in any
loss, damage, expense, liability, claim or action arising out of or based upon
matters covered by clause (i) or (ii) above (provided that the Company shall not
be liable under this clause (iii) to the extent it is finally judicially
determined by a court of competent jurisdiction that such loss, damage, expense,
liability, claim or action resulted directly from any such acts or failures to
act undertaken or omitted to be taken by the Underwriters through their gross
negligence or willful misconduct), except insofar as any such loss, damage,
expense, liability or claim arises out of or is based upon any untrue statement
or alleged untrue statement of a material fact contained in and in conformity
with information furnished in writing by or on behalf of any Underwriter through
Merrill Lynch to the Company expressly for use with reference to such
Underwriter in the Prospectus or any Issuer Free Writing Prospectus or arises
out of or is based upon any omission or alleged omission to state a material
fact in connection with such information required to be stated in the Prospectus
or necessary to make such information not misleading.

                  If any action, suit or proceeding (together, a "Proceeding")
is brought against an Underwriter or any such Person in respect of which
indemnity may be sought against the Company pursuant to the foregoing paragraph,
such Underwriter or such Person shall promptly notify the Company in writing of
the institution of such Proceeding; provided, however, that the omission to so
notify the Company shall not relieve the Company from any liability which the
Company may have to any Underwriter or any such Person or otherwise. Merrill
Lynch shall have the right to employ counsel for such indemnified parties and
the Company shall indemnify the Underwriter or any such Person in respect of
which indemnity may be sought against the Company pursuant to the foregoing
paragraph, against any and all expense whatsoever, as incurred (including the
fees and disbursements of counsel), reasonably incurred in investigating,
preparing or defending against any Proceeding. The Company may participate at
its own expense in the defense of any such action; provided, however, that
counsel to the Company shall not (except with the consent of the indemnified
party) also be counsel to the indemnified party. In no event shall the Company
be liable for fees and expenses of more than one counsel (in addition to any
local counsel) separate from its own counsel for all indemnified parties in
connection with any one action or separate but similar or related actions in the
same jurisdiction arising out of the same general allegations or circumstances.
The Company shall not be liable for any settlement of any such Proceeding
effected without its written consent (which shall not be unreasonably withheld)
but if settled with the written consent of the Company, the Company agrees to
indemnify and hold harmless any Underwriter and any such Person from and against
any loss or liability by reason of such settlement. Notwithstanding the
foregoing sentence, if at any time an indemnified party shall have requested an
indemnifying party to reimburse the indemnified party for fees and expenses of
counsel as contemplated by the second sentence of this paragraph, then the
indemnifying party agrees that it shall be liable for any settlement of any
Proceeding effected without its written consent if (i) such settlement is
entered into more than 60 Business Days after receipt by such indemnifying party
of the aforesaid request, (ii) such indemnifying party shall not have reimbursed
the indemnified party in accordance with such request prior to the date of such
settlement and (iii) such indemnified party shall have given the indemnifying
party at least 30 days' prior notice of its intention to settle. No indemnifying
party shall, without the prior written consent of the indemnified party, effect
any settlement of any



                                      -25-



pending or threatened Proceeding in respect of which any indemnified party is or
could have been a party and indemnity could have been sought hereunder by such
indemnified party, unless such settlement includes an unconditional release of
such indemnified party from all liability on claims that are the subject matter
of such Proceeding and does not include an admission of fault, culpability or a
failure to act, by or on behalf of such indemnified party.

                  (b) Each Underwriter severally agrees to indemnify, defend and
hold harmless the Company, any Person who controls the Company within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act
and each director of the Company and each officer of the Company who signed the
Registration Statement from and against any loss, damage, expense, liability or
claim (including, but not limited to, the reasonable cost of investigation)
which, jointly or severally, the Company or any such Person may incur under the
Securities Act, the Exchange Act, federal or state statutory law or regulation,
the common law or otherwise, insofar as such loss, damage, expense, liability or
claim arises out of or is based upon any (i) untrue statement or alleged untrue
statement of a material fact contained in, and in conformity with information
furnished in writing by or on behalf of such Underwriter through Merrill Lynch
to the Company expressly for use with reference to such Underwriter in, the
Registration Statement (or in the Registration Statement as amended by or on
behalf of any post-effective amendment thereof by the Company) or in a
Prospectus, or in any documents filed under the Exchange Act and deemed to be
incorporated by reference into the Prospectus or in any Issuer Free Writing
Prospectus, or in any application or other document executed by or on behalf of
the Company or based on written information furnished by or on behalf of the
Company filed in any jurisdiction in order to qualify the Shares under the
securities or blue sky laws thereof or filed with the Commission or (ii)
omission or alleged omission to state in any such document a material fact in
connection with such information required to be stated therein or necessary to
make the statement therein, in the light of the circumstances under which they
were made, not misleading.

                  If any Proceeding is brought against the Company or any such
Person in respect of which indemnity may be sought against any Underwriter
pursuant to the foregoing paragraph, the Company or such Person shall promptly
notify such Underwriter in writing of the institution of such Proceeding;
provided, however, that the omission to so notify such Underwriter shall not
relieve such Underwriter, from any liability which such Underwriter may have to
the Company or any such Person or otherwise. The Company shall have the right to
employ its own counsel in any such case and such Underwriter shall indemnify the
Company or any such Person in respect of which indemnity may be sought against
such Underwriter pursuant to the foregoing paragraph, against any and all
expense whatsoever, as incurred (including the fees and disbursements of counsel
chosen by the Company), reasonably incurred in investigating, preparing or
defending against any Proceeding. Such Underwriter may participate at its own
expense in the defense of any such action; provided, however, that counsel to
such Underwriter shall not (except with the consent of the indemnified party)
also be counsel to the indemnified party. In no event shall such Underwriter be
liable for fees and expenses of more than one counsel (in addition to any local
counsel) separate from its own counsel for all indemnified parties in connection
with any one action or separate but similar or related actions in the same
jurisdiction arising out of the same general allegations or circumstances. No
Underwriter shall be liable for any settlement of any such Proceeding effected
without the written consent of such Underwriter but if settled with the written
consent of such Underwriter, such Underwriter agrees



                                      -26-



to indemnify and hold harmless the Company and any such Person from and against
any loss or liability by reason of such settlement. Notwithstanding the
foregoing sentence, if at any time an indemnified party shall have requested an
indemnifying party to reimburse the indemnified party for fees and expenses of
counsel as contemplated by the second sentence of this paragraph, then the
indemnifying party agrees that it shall be liable for any settlement of any
Proceeding effected without its written consent if (i) such settlement is
entered into more than 60 Business Days after receipt by such indemnifying party
of the aforesaid request, (ii) such indemnifying party shall not have reimbursed
the indemnified party in accordance with such request prior to the date of such
settlement and (iii) such indemnified party shall have given the indemnifying
party at least 30 days' prior notice of its intention to settle. No indemnifying
party shall, without the prior written consent of the indemnified party, effect
any settlement of any pending or threatened Proceeding in respect of which any
indemnified party is or could have been a party and indemnity could have been
sought hereunder by such indemnified party, unless such settlement includes an
unconditional release of such indemnified party from all liability on claims
that are the subject matter of such Proceeding.

                  (c) If the indemnification provided for in this Section 9 is
unavailable to an indemnified party under subsections (a) and (b) of this
Section 9 in respect of any losses, damages, expenses, liabilities or claims
referred to therein, then in order to provide just and equitable contribution in
such circumstance, each applicable indemnifying party, in lieu of indemnifying
such indemnified party, shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, damages, expenses, liabilities or
claims (i) in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and the Underwriters on the other hand
from the offering of the Shares or (ii) if, but only if, the allocation provided
by clause (i) above is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i)
above but also the relative fault of the Company on the one hand and of the
Underwriters on the other in connection with the statements or omissions which
resulted in such losses, damages, expenses, liabilities or claims, as well as
any other relevant equitable considerations. The relative benefits received by
the Company on the one hand and the Underwriters on the other shall be deemed to
be in the same respective proportion as the total proceeds from the offering
(net of underwriting discounts and commissions but before deducting expenses)
received by the Company and the total underwriting discounts and commissions
received by the Underwriters, bear to the aggregate public offering price of the
shares. The relative fault of the Company on the one hand and of the
Underwriters on the other shall be determined by reference to, among other
things, whether the untrue statement or alleged untrue statement of a material
fact or omission or alleged omission relates to information supplied by the
Company or by the Underwriters and the parties' relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or
omission. The amount paid or payable by a party as a result of the losses,
damages, expenses, liabilities and claims referred to in this subsection shall
be deemed to include any legal or other fees or expenses reasonably incurred by
such party in connection with investigating, preparing to defend or defending
any claim or Proceeding.

                  (d) The Company and the Underwriters agree that it would not
be just and equitable if contribution pursuant to this Section 9 were determined
by pro rata allocation (even if the Underwriters were treated as one entity for
such purpose) or by any other method of allocation that does not take account of
the equitable considerations referred to in subsection (c)



                                      -27-



above. Notwithstanding the provisions of this Section 9, no Underwriter shall be
liable or responsible for, or be required to contribute, any amount pursuant to
this Section 9 in excess of the amount of the underwriting discounts and
commissions applicable to the Shares purchased by such Underwriter. No Person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any Person who was
not guilty of such fraudulent misrepresentation. The Underwriters' obligations
to contribute pursuant to this Section 9 are several in proportion to their
respective underwriting commitments and not joint.

                  (e) The indemnity and contribution agreements contained in
this Section 9 and the covenants, warranties and representations of the Company
contained in this Agreement shall remain in full force and effect regardless of
any investigation made by or on behalf of any Underwriter, its directors and
officers or any Person (including each partner, officer or director of such
Person) who controls any Underwriter within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act, or by or on behalf of the
Company, its directors or officers or any Person who controls the Company within
the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act, and shall survive any termination of this Agreement or the issuance and
delivery of the Shares. The Company and each Underwriter agree promptly to
notify each other upon the commencement of any Proceeding against it and, in the
case of the Company, against any of the Company's officers or directors in
connection with the issuance and sale of the Shares, including the shares of
Common Stock issued upon conversion of the Shares, or in connection with the
Registration Statement or the Prospectus.

                  10. NOTICES. Except as otherwise herein provided, all
statements, requests, notices and agreements shall be in writing or by telegram
and, if to the Underwriters, shall be sufficient in all respects if delivered or
sent to Merrill Lynch & Co., 4 World Financial Center, New York, New York 10080,
Attention: Lee Shavel, with a copy for information purposes to Valerie Ford
Jacob, Esq. at Fried, Frank, Harris, Shriver & Jacobson LLP, One New York Plaza,
New York, NY 10004 and if to the Company, shall be sufficient in all respects if
delivered or sent to the Company at the offices of the Company at 1211 Avenue of
the Americas, Suite 2902, New York, New York 10036, Attention: Michael A.J.
Farrell with a copy for information purposes to Phillip Kardis, Esq. at
Kirkpatrick & Lockhart Nicholson Graham, 1601 K Street NW, Washington, D.C.
20006.

                  11. GOVERNING LAW; CONSTRUCTION. This Agreement and any claim,
counterclaim or dispute of any kind or nature whatsoever arising out of or in
any way relating to this Agreement (a "Claim"), directly or indirectly, shall be
governed by, and construed in accordance with, the laws of the State of New
York. The Section headings in this Agreement have been inserted as a matter of
convenience of reference and are not a part of this Agreement.

                  12. SUBMISSION TO JURISDICTION. Except as set forth below, no
Claim may be commenced, prosecuted or continued in any court other than the
courts of the State of New York located in the City and County of New York or in
the United States District Court for the Southern District of New York, which
courts shall have jurisdiction over the adjudication of such matters, and the
Company consents to the non-exclusive jurisdiction of such courts and personal
service with respect thereto. The Company hereby consents to personal
jurisdiction, service and venue in any court in which any Claim arising out of
or in any way relating to this Agreement is



                                      -28-



brought by any third party against Merrill Lynch or any indemnified party. Each
of Merrill Lynch and the Company (on its behalf and, to the extent permitted by
applicable law, on behalf of its stockholders and affiliates) waives all right
to trial by jury in any action, proceeding or counterclaim (whether based upon
contract, tort or otherwise) in any way arising out of or relating to this
Agreement. The Company agrees that a final judgment in any such action,
proceeding or counterclaim brought in any such court shall be conclusive and
binding upon the Company and may be enforced in any other courts in the
jurisdiction of which the Company is or may be subject, by suit upon such
judgment.

                  13. PARTIES AT INTEREST. The Agreement herein set forth has
been and is made solely for the benefit of the Underwriters, the Company and to
the extent provided in Section 9 hereof the controlling Persons, directors and
officers referred to in such Section, and their respective successors, assigns,
heirs, pursuant representatives and executors and administrators. No other
Person, partnership, association or corporation (including a purchaser, as such
purchaser, from any of the Underwriters) shall acquire or have any right under
or by virtue of this Agreement.

                  14. NO ADVISORY OR FIDUCIARY RELATIONSHIP. The Company
acknowledges and agrees that (a) the purchase and sale of the Shares pursuant to
this Agreement, including the determination of the public offering price of the
Shares and any related discounts and commissions, is an arm's-length commercial
transaction between the Company, on the one hand, and the several Underwriters,
on the other hand, (b) in connection with the offering contemplated hereby and
the process leading to such transaction each Underwriter is and has been acting
solely as a principal and is not the agent or fiduciary of the Company, or its
respective stockholders, creditors, employees or any other party, (c) no
Underwriter has assumed or will assume an advisory or fiduciary responsibility
in favor of the Company with respect to the offering contemplated hereby or the
process leading thereto (irrespective of whether such Underwriter has advised or
is currently advising the Company on other matters) and no Underwriter has any
obligation to the Company with respect to the offering contemplated hereby
except the obligations expressly set forth in this Agreement, (d) the
Underwriters and their respective affiliates may be engaged in a broad range of
transactions that involve interests that differ from those of each of the
Company, and (e) the Underwriters have not provided any legal, accounting,
regulatory or tax advice with respect to the offering contemplated hereby and
the Company has consulted its own respective legal, accounting, regulatory and
tax advisors to the extent it deemed appropriate.

                  15. TAX DISCLOSURE. Notwithstanding any other provision of
this Agreement, immediately upon commencement of discussions with respect to the
transactions contemplated hereby, the Company (and each employee, representative
or other agent of the Company) may disclose to any and all persons, without
limitation of any kind, the tax treatment and tax structure of the transactions
contemplated by this Agreement and all materials of any kind (including opinions
or other tax analyses) that are provided to the Company relating to such tax
treatment and tax structure. For purposes of the foregoing, the term "tax
treatment" is the purported or claimed federal income tax treatment of the
transactions contemplated hereby, and the term "tax structure" includes any fact
that may be relevant to understanding the purported or claimed federal income
tax treatment of the transactions contemplated hereby.



                                      -29-



                  16. REPRESENTATIONS, WARRANTIES AND AGREEMENTS TO SURVIVE. All
representations, warranties and agreements contained in this Agreement or in
certificates of officers of the Company or any of its subsidiaries submitted
pursuant hereto, shall remain operative and in full force and effect regardless
of (i) any investigation made by or on behalf of any Underwriter or its
Affiliates or selling agents, any person controlling any Underwriter, its
officers or directors or any person controlling the Company, and (ii) delivery
of and payment for the Shares.

                  17. INTEGRATION. This Agreement supersedes all prior
agreements and understandings (whether written or oral) between the Company and
the Underwriters, or any of them, with respect to the subject matter hereof.

                  18. COUNTERPARTS. This Agreement may be signed by the parties
in one or more counterparts which together shall constitute one and the same
agreement among the parties.

                  19. SUCCESSORS AND ASSIGNS. This Agreement shall be binding
upon the Underwriters and the Company and their successors and assigns and any
successor or assign of any substantial portion of the Company's and any of the
Underwriters' respective businesses and/or assets.

                  20. TIME. TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT.
EXCEPT AS OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK
CITY TIME.

                  If the foregoing correctly sets forth the understanding among
the Company and the Underwriters, please so indicate in the space provided below
for the purpose, whereupon this letter and your acceptance shall constitute a
binding agreement among the Company and the Underwriters, severally.

                           Very truly yours,


                           ANNALY MORTGAGE MANAGEMENT, INC.


                           By:  /s/ Michael A.J. Farrell
                              ----------------------------
                                Name:  Michael A.J. Farrell
                                Title: Chairman of the Board, Chief Executive
                                         Officer and President




                                      -30-



Accepted and agreed to as of the date first
above written, on behalf of itself and the
other several Underwriters named in Schedule A


MERRILL LYNCH & CO.
MERRILL LYNCH, PIERCE, FENNER & SMITH
            INCORPORATED
BEAR, STEARNS & CO. INC.


BY: MERRILL LYNCH, PIERCE, FENNER & SMITH
               INCORPORATED


By /s/ Richard Ginn
  -----------------
             Authorized Signatory

For themselves and as Representative(s) of the other Underwriters named in
Schedule A hereto.

























                                      -31-






                                   SCHEDULE A




                                                                     NUMBER OF
UNDERWRITER                                                         FIRM SHARES
-----------                                                         -----------
Merrill Lynch, Pierce, Fenner & Smith Incorporated..............     3,000,000
Bear, Stearns & Co. Inc. .......................................     1,000,000
                                                                     ---------
         Total..................................................     4,000,000
                                                                     =========























                                     Sch-A




                                   SCHEDULE B

                   Issuer General Use Free Writing Prospectus
                                (attached hereto)



Final Term Sheet



























                                     Sch-B





                                    EXHIBIT A

           FORM OF ARTICLES SUPPLEMENTARY OF 6.00% SERIES B CUMULATIVE
                           CONVERTIBLE PREFERRED STOCK

                                (Attached hereto)



































                                    Ex. A-1




                                    EXHIBIT B

              OPINION OF KIRKPATRICK & NELSON NICHOLSON GRAHAM LLP


         1. The Company is a corporation duly incorporated, validly existing and
in good standing under the laws of the State of Maryland, with the corporate
power and authority to own, lease and operate its properties and conduct its
business as described in the Prospectus and to enter into and perform its
obligations under or as contemplated by the Underwriting Agreement.

         2. The Company is duly qualified to do business as a foreign
corporation and is in good standing in each jurisdiction where the ownership or
leasing of its properties or the conduct of its business requires such
qualification, except where the failure to be so qualified and in good standing
would not have a Material Adverse Effect (with your permission, we have relied
in respect of matters of fact related to the opinion in this paragraph upon a
certificate of an officer of the Company).

         3. The Underwriting Agreement has been duly authorized, executed, and
delivered by the Company. The Articles Supplementary have been duly authorized
by all necessary corporate action on the part of the Company and filed for
record with SDAT.

         4. The Shares have been duly authorized by the Company for issuance and
sale to the Underwriters pursuant to the Underwriting Agreement and, when issued
and delivered by the Company pursuant to the Underwriting Agreement against
payment of the consideration set forth therein, will be validly issued, fully
paid and non-assessable and no holder of the Shares is or will be subject to
personal liability, under the General Corporation Law of the State of Maryland
(the "MGCL") or the Charter or By-laws of the Company, by reason of being a
holder. The Common Stock Shares have been duly authorized by the Company and,
upon their issuance and delivery on conversion of the Shares pursuant to the
Articles Supplementary, will be validly issued, fully paid and non-assessable
and no holder of the Common Stock Shares is or will be subject to personal
liability, under the MGCL or the Charter or By-laws of the Company, by reason of
being a holder.

         5. The Company has an authorized capitalization as of December 31, 2005
as set forth in the Prospectus Supplement under the caption "Capitalization."
All issued and outstanding shares of capital stock of the Company are validly
issued, fully paid, and non-assessable, and conform in all material respects
with the description thereof contained in the Prospectus. The Shares when issued
and outstanding will conform in all material respects with the description
thereof contained in the Prospectus.

         6. The issuance of the Shares is not subject to preemptive or other
similar rights of any stockholder of the Company arising by operation of the
MGCL or under the Charter or By-laws of the Company, or, to our knowledge, any
contractual preemptive rights, resale rights, rights of first refusal or similar
rights. To our knowledge, except as disclosed in the Registration Statement and
the Prospectus, there is no outstanding option, warrant or other right calling
for the issuance of, and no commitment, plan or arrangement to issue, any shares
of capital stock of the Company or any security convertible into, exercisable
for, or exchangeable for shares of


                                    Ex. B-1





capital stock of the Company. To our knowledge, no holder of any security of the
Company has the right to have any security owned by such holder included for
registration in the Registration Statement.

         7. The forms of certificate used by the Company to represent shares of
Preferred Stock comply in all material respects with any applicable requirement
of the MGCL and the Company's Charter and By-laws. The forms of certificate used
by the Company to represent the common stock, par value $0.01 per share, of the
Company comply in all material respects with any applicable requirement of the
MGCL, the Company's Charter and By-laws and the New York Stock Exchange.

         8. The information incorporated by reference into the Prospectus from
the Company's Form 10-K for the Company's fiscal year ending December 31, 2005
under the captions "Risk Factors - Risks of Ownership of Our Common Stock -
Maryland Business Combination Act", "Risk Factors - Risks of Ownership of Our
Common Stock - Maryland Control Share Acquisition Act", and the information in
the Prospectus under the caption "Description of Common Stock and Preferred
Stock" and in the Prospectus Supplement under the captions "Description of the
Series B Preferred Stock" and "Risk Factors - Our operations may be adversely
affected if we are subject to the Investment Company Act" to the extent that
such information constitutes a summary of legal matters under the MGCL or of
provisions of the Company's Charter or By-laws or the 1940 Act (as defined
below), has been reviewed by us and is correct in all material respects.

         9. The Registration Statement and the Prospectus (in each case other
than (A) the financial statements and supporting schedules and other financial
and accounting data included or incorporated by reference therein or omitted
therefrom as to which we express no opinion and (B) except as expressed in our
opinion in paragraph 10 below, the documents incorporated therein), as of their
respective effective dates, as the case may be, each complied, and as of the
date hereof each comply, as to form in all material respects to the applicable
requirements of the 1933 Act.

         10. The annual report on Form 10-K for the year ended December 31, 2005
and the definitive proxy statement filed with the Commission on April 5, 2006,
incorporated by reference in the Registration Statement (other than the
financial statements and supporting schedules and other financial and accounting
data included therein, as to which we express no opinion), when they were filed
with the Commission (or, if later, upon filing of an amendment thereto) complied
as to form in all material respects with the requirements of the Securities
Exchange Act of 1934, as amended, and the rules and regulations of the
Commission promulgated thereunder (collectively, the "1934 Act").

         11. The Registration Statement has been declared effective under the
1933 Act; the Prospectus has been filed pursuant to Rule 424(b) of the 1933 Act
in the manner and within the time period required by Rule 424(b); and, to our
knowledge, based solely on a telephone conversation with a member of the staff
of the Commission, no stop order suspending the effectiveness of the
Registration Statement has been issued under the 1933 Act and no proceedings for
that purpose have been initiated or threatened by the Commission.



                                    Ex. B-2



         12. To our knowledge, no consent, approval, authorization, or other
order of any federal regulatory body, federal administrative agency or other
federal governmental body of the United States of America or any state
regulatory body, state administrative agency or other state governmental body of
the State of Maryland is required under the Applicable Laws for the Company to
issue and sell the Shares to the Underwriters as contemplated by the
Underwriting Agreement and to consummate the transactions contemplated thereby.

         13. The execution and delivery of the Underwriting Agreement by the
Company, the performance by the Company of its obligations under the
Underwriting Agreement and the Articles Supplementary, and the issuance and sale
of the Shares to the Underwriters as contemplated by the Underwriting Agreement
and consummation of the transactions contemplated thereby do not and will not
conflict with or result in a breach or violation of any of the terms and
provisions of, constitute a default under, or cause a Repayment Event under (A)
any indenture, mortgage, deed of trust, lease, repurchase agreement or other
agreement, known to us, to which the Company is a party or is bound, except for
such for such violations, conflicts, breaches, defaults, liens, charges, or
encumbrances that would not result in a Material Adverse Effect, (B) the Charter
or By-laws of the Company, (C) Applicable Laws, (D) the Investment Company Act
of 1940, as amended (the "1940 Act"), or (E) or, to our knowledge, any judgment,
decree, order, rule, or regulation, of any court, other governmental authority,
or arbitrator having jurisdiction over the Company, except for such for such
violations, conflicts, breaches, defaults, liens, charges, or encumbrances that
would not result in a Material Adverse Effect. As used herein, a "Repayment
Event" means any event or condition which gives the holder of any note,
debenture or other evidence of indebtedness (or any person acting on such
holder's behalf) the right to require the repurchase, redemption or repayment of
all or a portion of such indebtedness by the Company or any subsidiary.

         14. The Company is not in violation of its Charter or By-laws, and, to
our knowledge, no default by the Company exists in the due performance or
observance of any material obligation, agreement, covenant, or condition
contained in any contract, indenture, mortgage, loan agreement, note, lease,
repurchase agreement, other agreement, or instrument that is described or
referred to in the Registration Statement or the Prospectus or filed or
incorporated by reference as an exhibit to the Registration Statement, except,
in each case above, for such for such violations, conflicts, breaches, defaults,
liens, charges, or encumbrances that would not result in a Material Adverse
Effect.

         15. To our knowledge, there are no actions, suits, claims,
investigations or proceedings pending or threatened to which the Company is or
would be a party or to which any of their respective properties is subject which
are required to be described in the Registration Statement or Prospectus but are
not so described.

         16. The Company is not, and the transactions contemplated by the
Underwriting Agreement will not cause the Company to become an "investment
company" or an entity "controlled" by an "investment company" under the 1940
Act.

In acting as counsel to the Company, we have participated in conferences with
officers and other representatives of the Company, the independent public
accountants for the Company, and your representatives, at which conferences the
contents of the Registration Statement and the



                                    Ex. B-3




Prospectus, and related matters were discussed. Although we are not passing upon
or assuming responsibility for the accuracy, completeness or fairness of the
statements included or incorporated by reference in the Registration Statement,
the Prospectus, the General Disclosure Package, or the Incorporated Documents
(as defined below) and have made no independent check or verification thereof
(except as set forth in paragraph eight above), on the basis of the foregoing,
nothing has come to our attention which has led us to believe that (i) the
Registration Statement, at the time the Registration Statement became effective,
contained an untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the statements therein
not misleading, (ii) the documents included in the General Disclosure Package,
as of the Applicable Time, contained any untrue statement of a material fact or
omitted to state any material fact necessary in order to make the statements
therein, in the light of circumstances under which they were made, not
misleading, or (iii) the Prospectus Supplement, as of its date or on the date
hereof, included or includes an untrue statement of a material fact or omitted
or omits to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading, except in each case that we express no belief and make no statement
with respect to financial statements and supporting schedules and other
financial and accounting data included or incorporated by reference in or
omitted from the Registration Statement, the Prospectus, the General Disclosure
Package, or the Incorporated Documents. With respect to statements contained in
the General Disclosure Package, any statement contained in any of the
constituent documents shall be deemed to be modified or superseded to the extent
that any information contained in subsequent constituent documents modifies or
replaces such statement. As used herein, the term "Incorporated Documents," when
used with respect to the Registration Statement or the Prospectus as of any
date, means the documents incorporated or deemed to be incorporated by reference
in the Registration Statement or the Prospectus, as the case may be, as of such
date pursuant to Item 12 of Form S-3.












                                    Ex. B-4




                                    EXHIBIT C

                           OPINION OF MCKEE NELSON LLP


                  For all taxable years commencing with its taxable year ended
December 31, 1997, the Company has been, and upon the sale of Shares will
continue to be, organized and operated in conformity with the requirements for
qualification and taxation as a "real estate investment trust" (a "REIT") under
Section 856 through 860 of the Internal Revenue Code of 1986, as amended (the
"Code"). The Company's proposed method of operation will enable the Company to
continue to meet the requirements for qualification and taxation as a REIT under
the Code, and no actions have been taken (or not taken which are required to be
taken) which would cause such qualification to be lost. The disclosure contained
in the Prospectus under the captions "Federal Income Tax Considerations", "Risk
Factors - We and Our Shareholders Are Subject To Certain Tax Risks" and in the
Prospectus Supplement under the caption "Federal Income Tax Considerations" to
the extent such information constitutes a summary of the United States federal
income tax laws and legal conclusions referred to therein, is accurate in all
material respects and fairly summarizes the federal income tax laws referred to
therein.

























                                    Ex. C-1




                                    EXHIBIT D



April 6, 2006


MERRILL LYNCH & CO.
Bear, Stearns & Co Inc.
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED,
   As representatives of the several Underwriters,
c/o Merrill Lynch & Co.
4 World Financial Center
New York, New York 10080

Ladies and Gentlemen:

                  In consideration of the agreement of Merrill Lynch & Co.,
Merrill Lynch, Pierce, Fenner & Smith Incorporated ("Merrill Lynch"), and
certain other underwriters to underwrite a proposed public offering (the
"Offering") of Series B Cumulative Convertible Preferred Stock (the "Preferred
Stock"), of Annaly Mortgage Management, Inc., a Maryland corporation (the
"Company"), as contemplated by a registration statement on Form S-3 (File No.
333-120920), as amended, including a prospectus (the "Registration Statement"),
the undersigned hereby agrees that the undersigned will not, for a period of 90
days after the commencement of the Offering, without the prior written consent
of Merrill Lynch, offer, sell, contract to sell, pledge, grant any option to
purchase or otherwise dispose of, directly or indirectly, any shares of capital
stock, or any securities convertible into, or exercisable, exchangeable or
redeemable for, shares of capital stock.

                  Notwithstanding the foregoing, if (1) during the last 17 days
of the 90-day restricted period the Company issues an earnings release or
material news or a material event relating to the Company occurs or (2) prior to
the expiration of the 90-day restricted period, the Company announces that it
will release earnings results or becomes aware that material news or a material
event will occur during the 16-day period beginning on the last day of the
90-day restricted period, the restrictions imposed in this agreement shall
continue to apply until the expiration of the 18-day period beginning on the
issuance of the earnings release or the occurrence of the material news or
material event.

                  The undersigned hereby acknowledges and agrees that written
notice of any extension of the lock-up period pursuant to the previous paragraph
will be delivered by Merrill Lynch, to the Company and that any such notice
properly delivered will be deemed to have been given to, and received by, the
undersigned. The undersigned further agrees that, prior to engaging in any
transaction or taking any other action that is subject to the terms of this
lock-up agreement during the period from the date of this lock-up agreement to
and including the 34th day following the expiration of the initial lock-up
period, it will give notice thereof to the Company and will not consummate such
transaction or take any such action unless it has



                                    Ex. D-1




received written confirmation from the Company that the lock-up period (as may
have been extended pursuant to the previous paragraph) has expired.


                                Very truly yours,




                                By:
                                   --------------------------------
                                    Name:
                                    Title:























                                    Ex. D-2